Microbot Medical Inc (MBOT) Will Continue To Grow In 2025.

In the latest trading session,, 1.69 million Microbot Medical Inc (NASDAQ:MBOT) shares changed hands as the company’s beta touched 1.16. With the company’s most recent per share price at $2.56 changing hands around $0.09 or 3.44% at last look, the market valuation stands at $92.94M. MBOT’s current price is a discount, trading about -32.03% off its 52-week high of $3.38. The share price had its 52-week low at $0.82, which suggests the last value was 67.97% up since then. When we look at Microbot Medical Inc’s average trading volume, we note the 10-day average is 1.24 million shares, with the 3-month average coming to 1.61 million.

Analysts gave the Microbot Medical Inc (MBOT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended MBOT as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Microbot Medical Inc’s EPS for the current quarter is expected to be -0.08.

Microbot Medical Inc (NASDAQ:MBOT) trade information

Instantly MBOT is in green as seen in intraday trades today. With action 1.39%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 138.79%, with the 5-day performance at 1.39% in the green. However, in the 30-day time frame, Microbot Medical Inc (NASDAQ:MBOT) is 3.44% up. Looking at the short shares, we see there were 8.06 million shares sold at short interest cover period of 4.25 days.

1 analysts are of the opinion that Microbot Medical Inc’s revenue for the current quarter will be 1M. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 15.51%. The 2025 estimates are for Microbot Medical Inc earnings to increase by 56.16%.

MBOT Dividends

Microbot Medical Inc is expected to release its next quarterly earnings report on 2025-May-14.

Microbot Medical Inc (NASDAQ:MBOT)’s Major holders

The share float percentage for the stock currently stands at 6.41%. There are 6.41% institutions holding the Microbot Medical Inc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 3.0953% of the shares, roughly 0.46 million MBOT shares worth $0.47 million.

BLACKROCK INC. holds the second largest percentage of outstanding shares, with 0.9253% or 0.14 million shares worth $0.14 million as of 2024-06-30.

Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . With 389.65 shares estimated at $0.98 million under it, the former controlled 1.07% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 0.96% of the shares, roughly 348.55 shares worth around $0.87 million.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.